UPDATE: Federal Court Denies Sequenom Preliminary Injunction Against Ariosa | GenomeWeb

The story has been updated to include comments by Sequenom.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that Sequenom's motion for a preliminary injunction against it has been denied by a federal court.

The US District Court for the Northern District of California has denied Sequenom's motion to prevent Ariosa from offering or selling its Harmony Prenatal Test, pending the ultimate resolution of the litigation between the two firms, Ariosa said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.

Sponsored by

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit. 

Sponsored by

This webinar will focus on a range of research and clinical applications enabled by improvements in mate pair technology for whole genome sequencing. 


Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.